Health Discovery Corporation (HDC) is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the fields of personalized medicine where such tools are critical to scientific discovery.

Health Discovery Corporation has a patent portfolio of 49 issued patents and 39 pending patent applications worldwide primarily on Support Vector Machine (SVM) technology. SVM is one of the leading approaches to pattern recognition and machine learning worldwide, and has been utilized in the following applications: homeland security techniques, text and image classification, handwriting and speech recognition, fingerprint identification, face recognition, fraud detection and security systems, financial securities and futures prediction, image analysis, protein structure prediction, medical diagnosis and prognosis, classification of microarray gene expression data, identifying consumer purchasing patterns, personal recommendation systems, weather prediction, decryption, engine knock detection and vehicle control and monitoring, prediction of traffic variables in transportation systems….. and now smart health iPhone apps with the launch of MelApp.

HDC’s primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology. For more information, visit www.healthdiscoverycorp.com.